Mezagitamab
迈泽妥单抗
Report date: 2026/04/14 20:00:15
Base Information
Drug NameMezagitamab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[34]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTakeda (China) International Trading Co LtdXOMA Royalty CorpVetter Pharma-Fertigung Gmbh & Co Kg +[6]
Inactive CompaniesN/A
Active Indications +[9]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A